ARCHIVES

Information Lacking On Use, Accuracy Of HER2 Tests

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999